{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:26:59Z","timestamp":1794108419165,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"BBSRC-AstraZeneca\/CASE studentship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Resolving inflammation is thought to return the affected tissue back to homoeostasis but recent evidence supports a non-linear model of resolution involving a phase of prolonged immune activity. Here we show that within days following resolution of\n                    <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                    -triggered lung inflammation, there is an influx of antigen specific lymphocytes with a memory and tissue-resident phenotype as well as macrophages bearing alveolar or interstitial phenotype. The transcriptome of these macrophages shows enrichment of genes associated with prostaglandin biosynthesis and genes that drive T cell chemotaxis and differentiation. Therapeutic depletion of post-resolution macrophages, inhibition of prostaglandin E2 (PGE\n                    <jats:sub>2<\/jats:sub>\n                    ) synthesis or treatment with an EP4 antagonist, MF498, reduce numbers of lung CD4\n                    <jats:sup>+<\/jats:sup>\n                    \/CD44\n                    <jats:sup>+<\/jats:sup>\n                    \/CD62L\n                    <jats:sup>+<\/jats:sup>\n                    and CD4\n                    <jats:sup>+<\/jats:sup>\n                    \/CD44\n                    <jats:sup>+<\/jats:sup>\n                    \/CD62L\n                    <jats:sup>-<\/jats:sup>\n                    \/CD27\n                    <jats:sup>+<\/jats:sup>\n                    T cells as well as their expression of the \u03b1-integrin, CD103. The T cells fail to reappear and reactivate upon secondary challenge for up to six weeks following primary infection. Concomitantly, EP4 antagonism through MF498 causes accumulation of lung macrophages and marked tissue fibrosis. Our study thus shows that PGE\n                    <jats:sub>2<\/jats:sub>\n                    signalling, predominantly via EP4, plays an important role during the second wave of immune activity following resolution of inflammation. This secondary immune activation drives local tissue-resident T cell development while limiting tissue injury\n                  <\/jats:p>","DOI":"10.1038\/s41467-024-48138-y","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T10:01:44Z","timestamp":1716285704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Post-resolution macrophages shape long-term tissue immunity and integrity in a mouse model of pneumococcal pneumonia"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9279-8053","authenticated-orcid":false,"given":"Karen T.","family":"Feehan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1769-9025","authenticated-orcid":false,"given":"Hannah E.","family":"Bridgewater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Stenkiewicz-Witeska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4041-0867","authenticated-orcid":false,"given":"Roel P. H.","family":"De Maeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3157-7262","authenticated-orcid":false,"given":"Matthias","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5650-5361","authenticated-orcid":false,"given":"Jeremy","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7326-1680","authenticated-orcid":false,"given":"Giuseppe","family":"Ercoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4997-5028","authenticated-orcid":false,"given":"Connar M.","family":"Mawer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3763-9380","authenticated-orcid":false,"given":"Arne N.","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R. W.","family":"Glanville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parinaaz","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia V.","family":"Bracken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1314-413X","authenticated-orcid":false,"given":"Anna","family":"Nicolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4419-0013","authenticated-orcid":false,"given":"Alexandra C.","family":"Kendall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3476-0844","authenticated-orcid":false,"given":"Derek W.","family":"Gilroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"key":"48138_CR1","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrd.2016.39","volume":"15","author":"JN Fullerton","year":"2016","unstructured":"Fullerton, J. N. & Gilroy, D. W. Resolution of inflammation: a new therapeutic frontier. Nat. Rev. Drug Discov. 15, 551\u2013567 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"48138_CR2","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/ni1276","volume":"6","author":"CN Serhan","year":"2005","unstructured":"Serhan, C. N. & Savill, J. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6, 1191\u20131197 (2005).","journal-title":"Nat. Immunol."},{"key":"48138_CR3","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.4049\/jimmunol.170.6.3223","volume":"170","author":"PK Potter","year":"2003","unstructured":"Potter, P. K., Cortes-Hernandez, J., Quartier, P., Botto, M. & Walport, M. J. Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells. J. Immunol. 170, 3223\u20133232 (2003).","journal-title":"J. Immunol."},{"key":"48138_CR4","doi-asserted-by":"publisher","first-page":"e0186964","DOI":"10.1371\/journal.pone.0186964","volume":"12","author":"MP Motwani","year":"2017","unstructured":"Motwani, M. P. et al. Prolonged immune alteration following resolution of acute inflammation in humans. PLoS One 12, e0186964 (2017).","journal-title":"PLoS One"},{"key":"48138_CR5","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1182\/blood-2014-03-562710","volume":"124","author":"J Newson","year":"2014","unstructured":"Newson, J. et al. Resolution of acute inflammation bridges the gap between innate and adaptive immunity. Blood 124, 1748\u20131764 (2014).","journal-title":"Blood"},{"key":"48138_CR6","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1016\/j.celrep.2017.08.098","volume":"20","author":"J Newson","year":"2017","unstructured":"Newson, J. et al. Inflammatory resolution triggers a prolonged phase of immune suppression through COX-1\/mPGES-1-derived prostaglandin E2. Cell Rep. 20, 3162\u20133175 (2017).","journal-title":"Cell Rep."},{"key":"48138_CR7","doi-asserted-by":"publisher","first-page":"e133042","DOI":"10.1172\/jci.insight.133042","volume":"5","author":"A Guillon","year":"2020","unstructured":"Guillon, A. et al. Pneumonia recovery reprograms the alveolar macrophage pool. JCI Insight 5, e133042 (2020).","journal-title":"JCI Insight"},{"key":"48138_CR8","doi-asserted-by":"publisher","first-page":"e150239","DOI":"10.1172\/jci.insight.150239","volume":"7","author":"EI Arafa","year":"2022","unstructured":"Arafa, E. I. et al. Recruitment and training of alveolar macrophages after pneumococcal pneumonia. JCI Insight 7, e150239 (2022).","journal-title":"JCI Insight"},{"key":"48138_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41590-019-0568-x","volume":"21","author":"H Aegerter","year":"2020","unstructured":"Aegerter, H. et al. Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection. Nat. Immunol. 21, 145\u2013157 (2020).","journal-title":"Nat. Immunol."},{"key":"48138_CR10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s41590-020-0673-x","volume":"21","author":"A Roquilly","year":"2020","unstructured":"Roquilly, A. et al. Alveolar macrophages are epigenetically altered after inflammation, leading to long-term lung immunoparalysis. Nat. Immunol. 21, 636\u2013648 (2020).","journal-title":"Nat. Immunol."},{"key":"48138_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","volume":"38","author":"S Yona","year":"2013","unstructured":"Yona, S. et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38, 79\u201391 (2013).","journal-title":"Immunity"},{"key":"48138_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0162-3109(83)90033-4","volume":"6","author":"RD Maca","year":"1983","unstructured":"Maca, R. D. The effects of prostaglandins on the proliferation of cultured human T lymphocytes. Immunopharmacology 6, 267\u2013277 (1983).","journal-title":"Immunopharmacology"},{"key":"48138_CR13","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.4049\/jimmunol.130.4.1770","volume":"130","author":"C Walker","year":"1983","unstructured":"Walker, C., Kristensen, F., Bettens, F. & deWeck, A. L. Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production. J. Immunol. 130, 1770\u20131773 (1983).","journal-title":"J. Immunol."},{"key":"48138_CR14","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.4049\/jimmunol.139.6.2075","volume":"139","author":"WL Farrar","year":"1987","unstructured":"Farrar, W. L., Evans, S. W., Rapp, U. R. & Cleveland, J. L. Effects of anti-proliferative cyclic AMP on interleukin 2-stimulated gene expression. J. Immunol. 139, 2075\u20132080 (1987).","journal-title":"J. Immunol."},{"key":"48138_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nm.1968","volume":"15","author":"C Yao","year":"2009","unstructured":"Yao, C. et al. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat. Med 15, 633\u2013640 (2009).","journal-title":"Nat. Med"},{"key":"48138_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cell.2008.07.025","volume":"134","author":"MO Li","year":"2008","unstructured":"Li, M. O. & Flavell, R. A. TGF-beta: a master of all T cell trades. Cell 134, 392\u2013404 (2008).","journal-title":"Cell"},{"key":"48138_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.immuni.2018.01.015","volume":"48","author":"LK Beura","year":"2018","unstructured":"Beura, L. K. et al. T cells in nonlymphoid tissues give rise to lymph-node-resident memory T cells. Immunity 48, 327\u2013338 e325 (2018).","journal-title":"Immunity"},{"key":"48138_CR18","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.3389\/fimmu.2018.01770","volume":"9","author":"FM Behr","year":"2018","unstructured":"Behr, F. M., Chuwonpad, A., Stark, R. & van Gisbergen, K. Armed and ready: transcriptional regulation of tissue-resident memory CD8 T cells. Front Immunol. 9, 1770 (2018).","journal-title":"Front Immunol."},{"key":"48138_CR19","doi-asserted-by":"publisher","first-page":"8098","DOI":"10.1016\/S0021-9258(18)34302-3","volume":"257","author":"JG Clark","year":"1982","unstructured":"Clark, J. G., Kostal, K. M. & Marino, B. A. Modulation of collagen production following bleomycin-induced pulmonary fibrosis in hamsters. Presence of a factor in lung that increases fibroblast prostaglandin E2 and cAMP and suppresses fibroblast proliferation and collagen production. J. Biol. Chem. 257, 8098\u20138105 (1982).","journal-title":"J. Biol. Chem."},{"key":"48138_CR20","first-page":"94","volume":"131","author":"JA Elias","year":"1985","unstructured":"Elias, J. A., Rossman, M. D., Zurier, R. B. & Daniele, R. P. Human alveolar macrophage inhibition of lung fibroblast growth. A prostaglandin-dependent process. Am. Rev. Respir. Dis. 131, 94\u201399, (1985).","journal-title":"Am. Rev. Respir. Dis."},{"key":"48138_CR21","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1172\/JCI112364","volume":"77","author":"PB Bitterman","year":"1986","unstructured":"Bitterman, P. B., Wewers, M. D., Rennard, S. I., Adelberg, S. & Crystal, R. G. Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. J. Clin. Investig. 77, 700\u2013708 (1986).","journal-title":"J. Clin. Investig."},{"key":"48138_CR22","doi-asserted-by":"publisher","first-page":"16988","DOI":"10.1016\/S0021-9258(18)71448-8","volume":"264","author":"A Fine","year":"1989","unstructured":"Fine, A., Poliks, C. F., Donahue, L. P., Smith, B. D. & Goldstein, R. H. The differential effect of prostaglandin E2 on transforming growth factor-beta and insulin-induced collagen formation in lung fibroblasts. J. Biol. Chem. 264, 16988\u201316991 (1989).","journal-title":"J. Biol. Chem."},{"key":"48138_CR23","doi-asserted-by":"publisher","first-page":"L1257","DOI":"10.1152\/ajplung.2001.281.5.L1257","volume":"281","author":"T Kohyama","year":"2001","unstructured":"Kohyama, T. et al. Prostaglandin E(2) inhibits fibroblast chemotaxis. Am. J. Physiol. Lung Cell Mol. Physiol. 281, L1257\u20131263, (2001).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"48138_CR24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1165\/rcmb.2002-0243OC","volume":"29","author":"JE Kolodsick","year":"2003","unstructured":"Kolodsick, J. E. et al. Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. Am. J. Respir. Cell Mol. Biol. 29, 537\u2013544 (2003).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"48138_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1165\/rcmb.2004-0126OC","volume":"32","author":"ES White","year":"2005","unstructured":"White, E. S. et al. Prostaglandin E(2) inhibits fibroblast migration by E-prostanoid 2 receptor-mediated increase in PTEN activity. Am. J. Respir. Cell Mol. Biol. 32, 135\u2013141 (2005).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"48138_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2012.08.009","volume":"695","author":"N Foudi","year":"2012","unstructured":"Foudi, N., Gomez, I., Benyahia, C., Longrois, D. & Norel, X. Prostaglandin E2 receptor subtypes in human blood and vascular cells. Eur. J. Pharm. 695, 1\u20136 (2012).","journal-title":"Eur. J. Pharm."},{"key":"48138_CR27","first-page":"4702","volume":"17","author":"S Xu","year":"2018","unstructured":"Xu, S., Zhou, W., Ge, J. & Zhang, Z. Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP\u2011PKA\/PI3K\u2011Akt signaling pathway. Mol. Med. Rep. 17, 4702\u20134712 (2018).","journal-title":"Mol. Med. Rep."},{"key":"48138_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1365-2125.2007.02997.x","volume":"65","author":"Y Mikaeloff","year":"2008","unstructured":"Mikaeloff, Y., Kezouh, A. & Suissa, S. Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Br. J. Clin. Pharm. 65, 203\u2013209 (2008).","journal-title":"Br. J. Clin. Pharm."},{"key":"48138_CR29","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1378\/chest.09-3102","volume":"139","author":"G Voiriot","year":"2011","unstructured":"Voiriot, G., Dury, S., Parrot, A., Mayaud, C. & Fartoukh, M. Nonsteroidal antiinflammatory drugs may affect the presentation and course of community-acquired pneumonia. Chest 139, 387\u2013394 (2011).","journal-title":"Chest"},{"key":"48138_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jcrc.2014.05.021","volume":"29","author":"J Messika","year":"2014","unstructured":"Messika, J. et al. Risks of nonsteroidal antiinflammatory drugs in undiagnosed intensive care unit pneumococcal pneumonia: younger and more severely affected patients. J. Crit. Care 29, 733\u2013738 (2014).","journal-title":"J. Crit. Care"},{"key":"48138_CR31","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ppul.23041","volume":"50","author":"MA Elemraid","year":"2015","unstructured":"Elemraid, M. A. et al. Risk factors for the development of pleural empyema in children. Pediatr. Pulmonol. 50, 721\u2013726 (2015).","journal-title":"Pediatr. Pulmonol."},{"key":"48138_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jpeds.2016.05.025","volume":"175","author":"M Le Bourgeois","year":"2016","unstructured":"Le Bourgeois, M. et al. Nonsteroidal anti-inflammatory drug without antibiotics for acute viral infection increases the empyema risk in children: a matched case-control study. J. Pediatr. 175, 47\u201353 e43 (2016).","journal-title":"J. Pediatr."},{"key":"48138_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00408-016-9973-1","volume":"195","author":"D Basille","year":"2017","unstructured":"Basille, D. et al. Non-steroidal anti-inflammatory drugs may worsen the course of community-acquired pneumonia: a cohort study. Lung 195, 201\u2013208 (2017).","journal-title":"Lung"},{"key":"48138_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.rmed.2016.12.005","volume":"123","author":"OS Kotsiou","year":"2017","unstructured":"Kotsiou, O. S., Zarogiannis, S. G. & Gourgoulianis, K. I. Prehospital NSAIDs use prolong hospitalization in patients with pleuro-pulmonary infection. Respir. Med 123, 28\u201333 (2017).","journal-title":"Respir. Med"},{"key":"48138_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/crj.12524","volume":"12","author":"K Krenke","year":"2018","unstructured":"Krenke, K. et al. Risk factors for local complications in children with community-acquired pneumonia. Clin. Respir. J. 12, 253\u2013261 (2018).","journal-title":"Clin. Respir. J."},{"key":"48138_CR36","doi-asserted-by":"publisher","first-page":"f6041","DOI":"10.1136\/bmj.f6041","volume":"347","author":"P Little","year":"2013","unstructured":"Little, P. et al. Ibuprofen, paracetamol, and steam for patients with respiratory tract infections in primary care: pragmatic randomised factorial trial. BMJ 347, f6041 (2013).","journal-title":"BMJ"},{"key":"48138_CR37","doi-asserted-by":"publisher","first-page":"e009769","DOI":"10.1136\/bmjopen-2015-009769","volume":"6","author":"P Little","year":"2016","unstructured":"Little, P. et al. Primary care randomised controlled trial of a tailored interactive website for the self-management of respiratory infections (Internet Doctor). BMJ Open 6, e009769 (2016).","journal-title":"BMJ Open"},{"key":"48138_CR38","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.cell.2015.08.030","volume":"163","author":"DM Fonseca","year":"2015","unstructured":"Fonseca, D. M. et al. Microbiota-dependent sequelae of acute infection compromise tissue-specific immunity. Cell 163, 354\u2013366 (2015).","journal-title":"Cell"},{"key":"48138_CR39","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.crohns.2013.01.010","volume":"7","author":"J Burisch","year":"2013","unstructured":"Burisch, J., Jess, T., Martinato, M., Lakatos, P. L. & EpiCom, E. The burden of inflammatory bowel disease in Europe. J. Crohns Colitis 7, 322\u2013337 (2013).","journal-title":"J. Crohns Colitis"},{"key":"48138_CR40","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jcp.41.4.467","volume":"41","author":"T Ashcroft","year":"1988","unstructured":"Ashcroft, T., Simpson, J. M. & Timbrell, V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41, 467\u2013470 (1988).","journal-title":"J. Clin. Pathol."},{"key":"48138_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.freeradbiomed.2012.08.565","volume":"59","author":"KA Massey","year":"2013","unstructured":"Massey, K. A. & Nicolaou, A. Lipidomics of oxidized polyunsaturated fatty acids. Free Radic. Biol. Med. 59, 45\u201355 (2013).","journal-title":"Free Radic. Biol. Med."},{"key":"48138_CR42","doi-asserted-by":"publisher","first-page":"e21976","DOI":"10.1096\/fj.202100380RRR","volume":"35","author":"D Camacho-Munoz","year":"2021","unstructured":"Camacho-Munoz, D. et al. Omega-3 carboxylic acids and fenofibrate differentially alter plasma lipid mediators in patients with non-alcoholic fatty liver disease. FASEB J. 35, e21976 (2021).","journal-title":"FASEB J."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48138-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48138-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48138-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T11:03:21Z","timestamp":1716289401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48138-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["48138"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-48138-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2162680\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,21]]},"assertion":[{"value":"13 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4326"}}